Education
About Us
Working with TipRanks
Follow Us
Zivo Bioscience (ZIVO)
:ZIVO
ZIVO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$5.80 - $22.15
Previous CloseN/A
Volume326.00
Average Volume (3M)345.00
Market Cap
$51.01M
Enterprise Value$51.86M
Total Cash (Recent Filing)$517.19K
Total Debt (Recent Filing)$893.13K
Price to Earnings (P/E)―
Beta0.41
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.35
Shares Outstanding3,813,517
10 Day Avg. Volume147
30 Day Avg. Volume345
Financial Highlights & Ratios
PEG Ratio0.21
Price to Book (P/B)-31.30
Price to Sales (P/S)0.00
P/FCF Ratio-12.73
Enterprise Value/Market Cap1.02
Enterprise Value/Revenue124.34
Enterprise Value/Gross Profit1.42K
Enterprise Value/Ebitda-0.92
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Zivo Bioscience News
PremiumCompany Announcements
Zivo Bioscience Issues Convertible Debt Offering
PremiumCompany Announcements
Zivo Bioscience Announces Board Election and Approvals
PremiumCompany Announcements
Zivo Bioscience Strengthens Board with New Director Appointment
PremiumCompany Announcements
Zivo Bioscience Enhances Equity Incentive Plans for Leadership
PremiumCompany Announcements
Zivo Bioscience Inc Faces Nasdaq Delisting and Shifts to OTC MarketsBulls Say, Bears Say
Bulls Say
Licensing AgreementsZIVO is engaged in constructive discussions with two major global animal health companies regarding potential licensing agreements for ZIVO’s coccidiosis product.
Poultry Health OpportunitiesPositive results from the avian flu study and plans for an additional trial are viewed favorably as it could expand ZIVO’s opportunities in poultry health.
Bears Say
Balance Sheet ConcernsThere is a risk that a deal does not come to fruition, combined with lingering concerns regarding the balance sheet and access to capital.
Capital Raising ChallengesOngoing challenges of raising capital as an unlisted security is a concern.
Cash And Debt SituationZIVO had cash and equivalents of $159K and debt of $355K, and it is expected to burn an average of $1.7M per quarter through 2025, relying on private placements or high interest-rate loans for funding.
Options Prices
Currently, No data available
---
Ownership Overview
46.25% Insiders
―
Mutual Funds
0.01% Other Institutional Investors
53.74% Public Companies and
Individual Investors
ZIVO FAQ
What was Zivo Bioscience ’s price range in the past 12 months?
Zivo Bioscience lowest stock price was $5.80 and its highest was $22.15 in the past 12 months.
What is Zivo Bioscience ’s market cap?
Zivo Bioscience ’s market cap is $51.01M.
When is Zivo Bioscience ’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Zivo Bioscience ’s earnings last quarter?
Currently, no data Available
Is Zivo Bioscience overvalued?
According to Wall Street analysts Zivo Bioscience ’s price is currently Overvalued.
Does Zivo Bioscience pay dividends?
Zivo Bioscience does not currently pay dividends.
What is Zivo Bioscience ’s EPS estimate?
Zivo Bioscience ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zivo Bioscience have?
Zivo Bioscience has 3,813,517 shares outstanding.
What happened to Zivo Bioscience ’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Zivo Bioscience ?
Currently, no hedge funds are holding shares in ZIVO
Zivo Bioscience Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
Insider Transactions
Bought Shares
Worth $50.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
60.21%
12-Months-Change
Fundamentals
Return on Equity
657.30%
Trailing 12-Months
Asset Growth
63.07%
Trailing 12-Months
Company Description
Zivo Bioscience
Zivo Bioscience (ZIVO) is a biotechnology company focused on the research and development of natural bioactive compounds derived from its proprietary algal cultures. The company operates primarily in the sectors of health and wellness, animal nutrition, and functional food ingredients. Zivo's main products include algal-derived compounds that are designed to improve health outcomes in both humans and animals through enhanced nutrition and immune support.